Drugs for Dowling-Degos Disease 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 65)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Clindamycin |
Approved, Vet_approved |
Phase 4 |
|
18323-44-9, 24729-96-2 |
29029 |
Synonyms:
7 Chloro 7 deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
ANTIROBE
Chlolincocin
Chlorlincocin
CHLORODEOXYLINCOMYCIN
CHLOROLINCOMYCIN
CLDM
Cleocin
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
CLEOCIN T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
CLINDAMYCIN
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
|
Clindamycin phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Evoclin
Hydrochloride, clindamycin
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
ResiDerm A
SOBELIN
U-21251
Zindaclin
|
|
2 |
|
Azelaic acid |
Approved |
Phase 4 |
|
123-99-9 |
2266 |
Synonyms:
1,7-Dicarboxyheptane
1,7-Heptanedicarboxylate
1,7-Heptanedicarboxylic acid
1,9-Nonanedioate
1,9-Nonanedioic acid
Acide azelaique
ACIDE AZÉLAÏQUE
ÁCIDO AZELAICO
ACIDUM ACELAICUM
Acidum azelaicum
alpha,omega-Nonanedioic acid
Anchoate
Anchoic acid
Azalaic acid
Azelaate
Azelaic acid
Azelaic acid, dilithium salt
Azelaic acid, dipotassium salt
Azelaic acid, disodium salt
Azelaic acid, monosodium salt
Azelaic acid, potassium salt
Azelaic acid, sodium salt
Azelaicacidtech
Azelainic acid
Azelainsaeure
AZELAINSÄURE
Azelate
|
Azelex
Azelic acid
Emerox 1110
Emerox 1144
Emery'S L-110
Finacea
Finevin
Heptanedicarboxylic acid
Lepargylate
Lepargylic acid
Monosodium azelate
N-Nonanedioate
N-Nonanedioic acid
Nonandisaeure
NONANDISÄURE
Nonanedioate
Nonanedioic acid
Nonanedioic acid azelaic acid
Nonanedioic acid homopolymer
NSC-19493
Poly(azelaic anhydride)
Polyazelaic anhydride
Skinorem
Skinoren
ZK-62498
α,ω-Nonanedioic acid
|
|
3 |
|
Nicotinamide |
Approved, Investigational |
Phase 4 |
|
98-92-0 |
936 |
Synonyms:
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
Acid amide
Amid kyseliny nikotinove
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra brand OF niacinamide
Austrovit PP
b 3, Vitamin
b3, Vitamin
Benicot
beta-Pyridinecarboxamide
b-Pyridinecarboxamide
Delonin amide
Dipegyl
Dipigyl
Endobion
Enduramide
Factor PP
FREEDERM
Hansamid
Inovitan PP
Jenapharm brand OF niacinamide
Jenapharm, nicotinsäureamid
m-(Aminocarbonyl)pyridine
Mediatric
Merck brand OF niacinamide
NAM
Nandervit-N
Niacevit
Niacin
Niacinamide
Niacinamide astra brand
Niacinamide jenapharm brand
Niacinamide merck brand
Niacinamide pharmagenix brand
Niamide
NIATIN
Niavit PP
NICAM
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
|
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamide
Nicotinamidum
Nicotinate amide
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsäureamid jenapharm
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Niocinamide
Niozymin
NSC-13128
NSC-27452
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix brand OF niacinamide
PP-Faktor
Propamine a
PYRIDINE-3-CARBOXAMIDE
Pyridine-3-carboxylic acid amide
Savacotyl
Vi-nicotyl
Vi-noctyl
Vitamin b 3
Vitamin b3
Vitamin PP
Witamina PP
Β-pyridinecarboxamide
|
|
4 |
|
Desonide |
Approved, Investigational |
Phase 4 |
|
638-94-8 |
5311066 |
Synonyms:
11b,21-Dihydroxy-16a,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
11b,21-Dihydroxy-16a,17a-isopropylidenedioxypregna-1,4-diene-3,20-dione
11b,21-Dihydroxy-16a,17-isopropylidenedioxypregna-1,4-diene-3,20-dione
11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione
11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione
11Β,21-dihydroxy-16α,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
11Β,21-dihydroxy-16α,17-isopropylidenedioxypregna-1,4-diene-3,20-dione
11Β,21-dihydroxy-16α,17α-isopropylidenedioxypregna-1,4-diene-3,20-dione
16a,17a-Isopropylidenedioxyprednisolone
16a-Hydroxyprednisole-16,17-acetonide
16a-Hydroxyprednisolone-16a,17-acetonide
16alpha,17alpha-Isopropylidenedioxyprednisolone
16alpha-Hydroxyprednisole-16,17-acetonide
16alpha-Hydroxyprednisolone-16alpha,17-acetonide
16Α,17α-isopropylidenedioxyprednisolone
16Α-hydroxyprednisole-16,17-acetonide
16Α-hydroxyprednisolone-16α,17-acetonide
Alcon brand OF desonide
Bayer brand OF desonide
Clay park brand OF desonide
|
Clay-park brand OF desonide
CS Brand OF desonide
D2083
D-2083
Desfluorotriamcinolone acetonide
Desocort
DESONATE
Desone
Desonida
DESONIDE
Desonidum
Desowen
Galderma brand OF desonide
Locapred
Locatop
Owen brand OF desonide
Pierre fabre brand OF desonide
Prednacinolone
Tridesilon
Tridésonit
Verdeso
|
|
5 |
|
Trifarotene |
Approved, Investigational |
Phase 4 |
|
895542-09-3 |
11518241 |
Synonyms:
Aklief®|CD5789|compound 15b [PMID: 29706423]
CD5789
|
|
|
6 |
|
Ascorbic acid |
Approved, Nutraceutical |
Phase 4 |
|
50-81-7 |
54676860 54670067 5785 |
Synonyms:
(+)-Ascorbate
(+)-Ascorbic acid
(+)-Sodium L-ascorbate
[<sup>14</sup>C]-ascorbic acid
3-keto-L-Gulofuranolactone
3-oxo-L-Gulofuranolactone
AA
Acid, ascorbic
Acid, L-ascorbic
Acide ascorbique
Acido ascorbico
ácido ascórbico
Acidum ascorbicum
Acidum ascorbinicum
Adenex
Allercorb
Antiscorbic vitamin
Antiscorbutic vitamin
arco-Cee
Ascoltin
ASCOR
Ascorb
Ascor-b.i.d.
Ascorbajen
Ascorbate
Ascorbate radical
Ascorbate, ferrous
Ascorbate, magnesium
Ascorbate, sodium
ASCORBIC ACID
Ascorbic acid radical
Ascorbic acid, monosodium salt
Ascorbicab
Ascorbicap
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorin
Ascorteal
Ascorvit
Cantan
Cantaxin
Catavin C
Ce lent
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Ce-mi-lin
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-caps TC
Cetane-caps TD
Cetebe
Cetemican
Cevalin
Cevatine
Cevex
Cevi-bid
Cevimin
Ce-vi-sol
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
|
Ciamin
Cipca
Citriscorb
Citrovit
C-Level
C-Long
Colascor
Concemin
C-Quin
C-Span
C-Vimin
Davitamon C
Di-L-ascorbate, magnesium
Dora-C-500
Duoscorb
e 300
e300
e-300
Ferrous ascorbate
gamma-Lactone L-threo-hex-2-enonate
gamma-Lactone L-threo-hex-2-enonic acid
HiCee
Hybrin
ido-C
Juvamine
Kangbingfeng
Kyselina askorbova
L Ascorbic acid
L(+)-Ascorbate
L-(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbic acid
L-3-Ketothreohexuronic acid lactone
Laroscorbine
L-Ascorbate
L-Ascorbic acid
Lemascorb
Liqui-cee
L-Lyxoascorbate
L-Lyxoascorbic acid
L-threo-Ascorbic acid
L-Xyloascorbate
L-Xyloascorbic acid
Magnesium ascorbate
Magnesium ascorbicum
Magnesium di L ascorbate
Magnesium di-L-ascorbate
Magnorbin
Meri-c
Monodehydroascorbate radical
Monodehydroascorbic acid radical
Natrascorb
Natrascorb injectable
Planavit C
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Semidehydroascorbic acid
Sodascorbate
Sodium ascorbate
Suncoat VC 40
Testascorbic
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100m
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamina C
Vitamisin
Vitascorbol
Xitix
|
|
7 |
|
Isotretinoin |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
302-79-4, 4759-48-2 |
5538 444795 5282379 |
Synonyms:
(13-cis)-Retinoate
(13-CIS)-RETINOIC ACID
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)NONA-2,4,6,8-TETRAENOIC ACID
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENOIC ACID
(7E,9E,11E,13Z)-Retinoate
(7E,9E,11E,13Z)-RETINOIC ACID
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
13 cis Retinoic acid
13 CIS-RETINOIC ACID
13-cis-Retinoate
13-cis-Retinoate,isotretinoin
13-CIS-RETINOIC ACID
13-CIS-VITAMIN A ACID
13-RA
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoate (ecl)
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
Aberel
ABSORICA
ACCUTANE
Acid, all-trans-retinoic
Acid, beta-all-trans-retinoic
Acid, retinoic
Acid, trans-retinoic
Acid, vitamin a
Acide retinoique
ACIDE RETINOIQUE (FRENCH)
ACIDE RETINOIQUE (FRENCH) (DSL)
ACTICIN
AGN 100335
Airol
Aknefug
Aknoten
all trans Retinoic acid
all trans-Retinoic acid
all-(e)-Retinoate
all-(e)-Retinoic acid
all-trans-beta-Retinoate
all-trans-beta-Retinoic acid
all-trans-b-Retinoate
all-trans-b-Retinoic acid
all-trans-Retinoate
all-trans-Retinoic acid
ALL-TRANS-RETINOIC ACID (ATRA)
all-trans-retinoic acid (ATRA)|Altreno® (0.05% lotion)|Avita® (0.025% gel)|Renova® (0.02% cream)
all-trans-Tretinoin
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-Β-retinoate
all-trans-Β-retinoic acid
ALTRENO
AMNESTEEM
ATRA
Atra-IV
Atralin
Avita
beta all trans Retinoic acid
beta-all-trans-Retinoic acid
beta-Retinoate
beta-Retinoic acid
b-Retinoate
b-Retinoic acid
CIP-isotretinoin
CIS-RA
cis-Retinoate
|
CIS-RETINOIC ACID
CLARAVIS
Dermairol
Eudyna
ISOTRETINOIN
Isotretinoin zinc salt, 13 cis isomer
Isotretinoin zinc salt, 13-cis-isomer
Isotretinoina
Isotretinoína
Isotretinoine
Isotrétinoine
Isotretinoino
Isotretinoinum
ISOTREX
Lsotretinoin
MYORISAN
NEOVITAMIN A ACID
NSC-122758
PAT-001
Potassium salt, tretinoin
Renova
Retin a
Retin-a
Retin-a micro
RETIN-A-MICRO
Retinoate
Retinoic acid
RETINOIC ACID 13-CIS-FORM
Retionic acid
Retisol-a
Ro 1-5488
RO-43780
RO-4-3780
Roaccutan
ROACCUTANE
Roacutan
Salt, tretinoin potassium
Salt, tretinoin sodium
Salt, tretinoin zinc
Sodium salt, tretinoin
Solage
SOTRET
Stieva-a
Stieva-a Forte
Teriosal
trans Retinoic acid
trans-Retinoate
trans-Retinoic acid
Tretin m
Tretinoin
Tretinoin potassium salt
Tretinoin sodium salt
Tretinoin zinc salt
TRETINOIN、ATRA
Tretinoina
Trétinoïne
TRETINOINE (FRENCH)
TRETINOINE (FRENCH) (EINECS)
Tretinoinum
Tretin-X
Tri-Luma
Vesanoid
Vitamin a acid
Vitinoin
ZENATANE
Zinc salt, tretinoin
Β-retinoate
Β-retinoic acid
|
|
8 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
9 |
|
Niacin |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
59-67-6 |
938 |
Synonyms:
[<sup>3</sup>H]-nicotinic acid
3 Pyridinecarboxylic acid
3-CARBOXYLPYRIDINE
3-CARBOXYPYRIDINE
3-PICOLINIC ACID
3-PYRIDINECARBOXYLATE
3-PYRIDINECARBOXYLIC ACID
3-PYRIDYLCARBOXYLATE
3-PYRIDYLCARBOXYLIC ACID
ACIDE NICOTINIQUE
ACIDO NICOTINICO
ácido nicotínico
ACIDUM NICOTINICUM
AKOTIN
Aluminum salt, niacin
ANTI-PELLAGRA VITAMIN
APELAGRIN
beta-Pyridinecarboxylate
BETA-PYRIDINECARBOXYLIC ACID
b-Pyridinecarboxylate
b-Pyridinecarboxylic acid
DASKIL
EFACIN
ENDURACIN
Hydrochloride, niacin
INDURACIN
LINIC
Lithium nicotinate
m-Pyridinecarboxylate
M-PYRIDINECARBOXYLIC ACID
NIAC
NIACIN
Niacin aluminum salt
Niacin ammonium salt
Niacin calcium salt
Niacin cobalt (2+) salt
Niacin copper (2+) salt
Niacin hydrochloride
Niacin iron (2+) salt
Niacin lithium salt
Niacin lithium salt, hemihydrate
Niacin magnesium salt
Niacin manganese (2+) salt
Niacin potassium salt
Niacin sodium salt
Niacin tartrate
NIACIN TD
Niacin tosylate
Niacin zinc salt
niacin|nicotinate|vitamin B<sub>3</sub>|vitamin PP
Niacina
NIACINE
|
NIACOR
NIASPAN
NIASPAN ER
NIASPAN TITRATION STARTER PACK
NICACID
NICAMIN
NICANGIN
Nico 400
Nico400
Nico-400
NICOBID
NICOCAP
NICODELMINE
NICOLAR
NICONACID
NICOSAN 3
NICO-SPAN
NICOTINATE
Nicotinate, lithium
NICOTINIC ACID
NICOTINIPCA
NICYL
NIKOTINSAEURE
Nikotinsäure
NSC-169454
NYCLIN
P.P. FACTOR
PELLAGRA PREVENTIVE FACTOR
PELLAGRIN
PELONIN
PEVITON
Potassium salt, niacin
PP FACTOR
PYRIDINE-3-CARBOXYLIC ACID
Pyridine-b-carboxylate
Pyridine-b-carboxylic acid
Pyridine-beta-carboxylate
PYRIDINE-BETA-CARBOXYLIC ACID
Pyridine-β-carboxylate
PYRIDINE-Β-CARBOXYLIC ACID
SIMCOR
SLO-NIACIN
Sodium salt, niacin
Tartrate, niacin
TINIC
Tosylate, niacin
VITAMIN B3
VITAMIN PP
WAMPOCAP
Β-pyridinecarboxylate
Β-PYRIDINECARBOXYLIC ACID
|
|
10 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
11 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
12 |
|
Clindamycin, tretinoin drug combination |
|
Phase 4 |
|
|
|
13 |
|
Clindamycin phosphate |
|
Phase 4 |
|
|
32603 |
Synonyms:
Cleocin phosphate
Clindamycin phosphoric acid
Clindamycin-2-phosphate
|
|
|
14 |
|
Clindamycin palmitate |
|
Phase 4 |
|
|
|
15 |
|
Vitamins |
|
Phase 4 |
|
|
|
16 |
|
Keratolytic Agents |
|
Phase 4 |
|
|
|
17 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
18 |
|
Folate |
|
Phase 4 |
|
|
|
19 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
20 |
|
Vitamin B3 |
|
Phase 4 |
|
|
|
21 |
|
Nicotinic Acids |
|
Phase 4 |
|
|
|
22 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
23 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
24 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
25 |
|
Hypolipidemic Agents |
|
Phase 4 |
|
|
|
26 |
|
Lipid Regulating Agents |
|
Phase 4 |
|
|
|
27 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
28 |
|
Tranexamic acid |
Approved |
Phase 2, Phase 3 |
|
1197-18-8 |
5526 |
Synonyms:
(1R,4R)-4-(AMINOMETHYL)CYCLOHEXANE-1-CARBOXYLIC ACID
Acide tranexamique
Acide tranéxamique
Acido tranexamico
ácido tranexámico
Acidum tranexamicum
CL-65336
CL-65336|Cyclo-F®|Cyklokapron®|Femstrual®|trans AMCHA
CYCLO-F
CYKLO-F HEAVY PERIOD RELIEF
Cyklokapron
EXACYL
FEMSTRUAL
LB1148
LB-1148
LYSTEDA
MENSTRALITE
|
NSC-291305
RP-18429
Tranexamate
Tranexamic acid
Tranexamsaeure
Tranexmate
Tranexmic acid
Tranhexamate
Tranhexamic acid
trans AMCHA
trans-4-(Aminomethyl)cyclohexanecarboxylate
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-AMINOMETHYLCYCLOHEXANE-1-carboxylate
trans-4-AMINOMETHYLCYCLOHEXANE-1-carboxylIC ACID
trans-Amcha
trans-Tranexamate
trans-Tranexamic acid
|
|
29 |
|
Hemostatics |
|
Phase 2, Phase 3 |
|
|
|
30 |
|
Antifibrinolytic Agents |
|
Phase 2, Phase 3 |
|
|
|
31 |
|
Coagulants |
|
Phase 2, Phase 3 |
|
|
|
32 |
|
Hydroquinone |
Approved, Investigational |
Phase 2 |
|
123-31-9 |
785 |
Synonyms:
1,4-Benzenediol
1,4-Benzoquinol
1,4-Dihydroxy-benzeen
1,4-Dihydroxybenzen
1,4-Dihydroxybenzene
1,4-Dihydroxy-benzol
1,4-Diidrobenzene
1,4-p-Benzenediol
1,4-Phenylenediol
4-Hydroxyphenol
a-Hydroquinone
alpha-Hydroquinone
Artra
Benzene-1,4-diol
Benzohydroquinone
Benzoquinol
beta-Quinol
Black and white
BLACK AND WHITE BLEACHING CREAM
b-Quinol
CHEMBL537
Dihydroquinone
Dihydroxybenzene
Eldopaque
Eldopaque forte
Eldoquin
Eldoquin forte
Esoterica
Hidroquilaude
Hidroquin
Hidroquinona isdin
Hydrochinon
Hydrochinone
Hydroquinol
Hydroquinole
HYDROQUINONE
Hydroquinone for synthesis
Hydroquinone GR
|
Hydroquinone, copper (1+) salt
Hydroquinone, lead (2+) salt (2:1)
Hydroquinone, monocopper (2+) salt
Hydroquinoue
ICN brand 1 OF hydroquinone
ICN brand 2 OF hydroquinone
ICN brand 3 OF hydroquinone
ICN brand 4 OF hydroquinone
Idrochinone
Licostrata
Lustra
Melanasa
Melanex
Melpaque
Melquin
NCI-C55834
Neostrata HQ
NSC-9247
p-Benzenediol
p-Dihydroquinone
p-Dihydroxybenzene
P-Dioxobenzene
p-Dioxybenzene
Phiaquin
p-Hydroquinone
P-Hydroxybenzene
p-Hydroxyphenol
Plough brand 1 OF hydroquinone
Plough brand 2 OF hydroquinone
p-Phenylenediol
p-Quinol
Quinol
Solaquin
Solaquin forte
Stratus brand 1 OF hydroquinone
Stratus brand 2 OF hydroquinone
Ultraquin
|
|
33 |
|
Edetate calcium disodium anhydrous |
Approved, Vet_approved |
Phase 1, Phase 2 |
|
62-33-9, 60-00-4 |
6049 |
Synonyms:
(Ethylenedinitrilo)tetraacetate, ion(4-)
(ethylenedinitrilo)tetraacetic acid, ion(4−)
(Ethylenedinitrilo)tetraacetic acid, ion(4-)
{[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetate
{[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetIC ACID
2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetic acid
Acid, edetic
Acid, ethylenediaminetetraacetic
Acid, ethylenedinitrilotetraacetic
Acide edetique
Acide ethylenediaminetetracetique
Acido edetico
Acidum edeticum
CaEDTA
Calcioedetato de sodio
Calcitetracemate, disodium
Calcium disodium edetate
Calcium disodium edetic acid
Calcium disodium edta
Calcium disodium ethylenediamine tetraacetate
Calcium disodium ethylenediamine tetraacetic acid
Calcium disodium ethylenediaminetetraacetate
Calcium disodium ethylenediaminetetraacetic acid
Calcium disodium versenate
Calcium disodium versenic acid
Calcium edetate de sodium
CALCIUM EDETATE SODIUM
Calcium edetic acid de sodium
Calcium edta
Calcium sodium 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate (1/2/1)
Calcium sodium 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetic acid (1/2/1)
CALCIUM SODIUM EDETATE HYDRATE
Calcium sodium edta
Calcium tetacine
CaNa2Edta
Chelaton 3
Chromium edta
Copper edta
Coprin
Dicobalt edta
Dinitrilotetraacetate, disodium ethylene
Dinitrilotetraacetate, ethylene
Disodium calcitetracemate
Disodium calcium edta
Disodium calcium ethylenediaminetetraacetate
Disodium calcium ethylenediaminetetraacetic acid
Disodium edta
Disodium ethylene dinitrilotetraacetate
Disodium monocalcium edta
Disodium versenate, calcium
Distannous edta
E385
Edathamil
Edetate
Edetate calcium
Edetate calcium disodium
Edetate calcium disodium (anhydrous)
Edetate disodium calcium
Edetate, calcium disodium
Edetates
|
Edetic acid
Edetic acid calcium disodium
Edetic acid calcium disodium (anhydrous)
Edetic acid calcium disodium salt
Edetic acid, calcium salt
Edetic acid, calcium, sodium salt
Edetic acid, chromium salt
Edetic acid, dipotassium salt
Edetic acid, disodium salt
Edetic acid, disodium salt, dihydrate
Edetic acid, disodium, magnesium salt
Edetic acid, disodium, monopotassium salt
Edetic acid, magnesium salt
Edetic acid, monopotassium salt
Edetic acid, monosodium salt
Edetic acid, potassium salt
Edetic acid, sodium salt
EDT
EDTA
EDTA CALCIUM DISODIUM
EDTA calcium disodium salt
EDTA disodium calcium salt
EDTA, calcium derivative, disodium salt
EDTA, chromium
EDTA, copper
EDTA, dicobalt
EDTA, disodium
EDTA, distannous
EDTA, gallium
EDTA, ion(4-)
EDTA, magnesium disodium
EDTA, potassium
EDTA, stannous
EDTHAMIL
Ethylene dinitrilotetraacetate
Ethylene dinitrilotetraacetate, disodium
Ethylenediaminetetraacetate
Ethylenediaminetetraacetate calcium disodium salt
Ethylenediaminetetraacetic acid
Ethylenediaminetetraacetic acid calcium disodium salt
Ethylenedinitrilotetraacetic acid
Gallium edta
H4EDta
Magnesium disodium edta
Monocalcium disodium edta
N,N'-1,2-ethane diylbis-(N-(carboxymethyl)glycine)
N,N'-1,2-ethanediylbis(N-(carboxymethyl)glycine)
Natrii calcii edetas
Potassium edta
Sodium calcium edetate
Sodium calcium edetic acid
SODIUM CALCIUMEDETATE
Stannous edta
Tetacine, calcium
Tetracemate
Versenate
Versenate, calcium disodium
Versene
Versene acid
VERSENE CA
|
|
34 |
|
Iron |
Approved |
Phase 1, Phase 2 |
|
7439-89-6 |
29936 |
Synonyms:
Carbonyl iron
Eisen
Electrolytic iron
Fe
FE (III) ion
Fe(3+)
Fe(III)
fer
Ferric ion
Ferric iron
Ferrum
|
Ferrum metallicum
Hierro
Iron powder
Iron(3+)
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, reduced
Reduced iron
|
|
35 |
|
Zinc cation |
Approved, Experimental, Investigational |
Phase 1, Phase 2 |
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
36 |
|
Pentetic acid |
Approved |
Phase 1, Phase 2 |
|
67-43-6 |
|
Synonyms:
[[(Carboxymethyl)imino]bis(1,2-ethanediylnitrilo)tetraacetate]
[[(Carboxymethyl)imino]bis(1,2-ethanediylnitrilo)tetraacetic acid]
1,1,4,7,7-Diethylenetriaminepentaacetate
1,1,4,7,7-Diethylenetriaminepentaacetic acid
Ca-dtpa
CaDTPA
Calcium trisodium pentetate
CaNa-dtpa
Complexon V
DETAPAC
Diethylene triamine pentaacetic acid
Diethylenetriamine pentaacetic acid
Diethylenetriamine-N,N,n',n'',n''-pentaacetate
Diethylenetriamine-N,N,n',n'',n''-pentaacetic acid
Diethylenetriaminepentaacetate
Diethylenetriaminepentaacetic acid
Diethylenetriaminepentacetate
Diethylenetriaminepentacetic acid
DTPA
DTP-A
H5dTpa
Indium dtpa
|
Indium-dtpa
MN-Dtpa
N,N,N',n'',n''-diethylenetriaminepentaacetate
N,N,N',n'',n''-diethylenetriaminepentaacetic acid
N,N-Bis[2-[bis(carboxymethyl)amino]ethyl]glycine
NSC-7340
Pentaacetic acid, diethylenetriamine
Pentacarboxymethyldiethylenetriamine
Pentacin
Pentacine
Pentaind
Pentetate
Pentetate calcium trisodium
Pentetate zinc trisodium
Pentetate, calcium trisodium
Pentetates
PENTETIC ACID
Penthanil
sn-DTPA
Titriplex V
Zinc dtpa
Zinc-dtpa
|
|
37 |
|
Ruboxistaurin |
Investigational |
Phase 2 |
|
169939-94-0 |
9892366 153999 |
Synonyms:
|
38 |
|
Sunscreening Agents |
|
Phase 2 |
|
|
|
39 |
|
Radiation-Protective Agents |
|
Phase 2 |
|
|
|
40 |
|
Antioxidants |
|
Phase 2 |
|
|
|
41 |
|
Protective Agents |
|
Phase 1, Phase 2 |
|
|
|
42 |
|
Trace Elements |
|
Phase 1, Phase 2 |
|
|
|
43 |
|
Micronutrients |
|
Phase 1, Phase 2 |
|
|
|
44 |
|
Pharmaceutical Solutions |
|
Phase 1, Phase 2 |
|
|
|
45 |
|
Hormones |
|
Phase 1, Phase 2 |
|
|
|
46 |
|
Iron Chelating Agents |
|
Phase 1, Phase 2 |
|
|
|
47 |
|
Antidotes |
|
Phase 1, Phase 2 |
|
|
|
48 |
|
Calcium, Dietary |
|
Phase 1, Phase 2 |
|
|
|
49 |
|
Anticoagulants |
|
Phase 1, Phase 2 |
|
|
|
50 |
|
Chelating Agents |
|
Phase 1, Phase 2 |
|
|
|
Interventional clinical trials:
(show all 50)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy & Safety of Clindamycin Phosphase 1.2% and Tretinoin 0.025% Gel vs. Vehicle for the Treatment of Acne and Acne-Induced Post Inflammatory Hyperpigmentation in Patients With Skin of Color |
Unknown status |
NCT01111994 |
Phase 4 |
Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel |
2 |
Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation: Histological and Clinical Randomized Study |
Completed |
NCT03252418 |
Phase 4 |
Ascorbic Acid 500 MG |
3 |
A Single Blind, Placebo Controlled Trial to Evaluate Effects of a Study Medication, a Nu Skin Lightening Product With and Without Iontophoresis vs Tretinoin Cream vs Vehicle Control for Facial Hyperpigmentation |
Completed |
NCT01149876 |
Phase 4 |
Tretinoin cream 0.05 |
4 |
Efficacy and Safety of Finacea in the Treatment of Post-Inflammatory Hyperpigmentation and Acne Vulgaris |
Completed |
NCT01038869 |
Phase 4 |
Azelaic acid |
5 |
A Double Blind, Randomized Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation |
Completed |
NCT01542138 |
Phase 4 |
Desonide;Niacinamide;Placebo |
6 |
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System |
Completed |
NCT02138539 |
Phase 4 |
Hydroquinone |
7 |
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color |
Completed |
NCT03402893 |
Phase 4 |
ONEXTON Topical Gel |
8 |
Evaluation of Acne-induced Hyperpigmentation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks |
Active, not recruiting |
NCT05089708 |
Phase 4 |
Trifarotene Cream;Trifarotene Vehicle Cream |
9 |
Evaluation of the Therapeutic Effect of Platelet Rich Plasma (PRP) in Periorbital Hyperpigmentation(POH) |
Unknown status |
NCT03862118 |
Phase 3 |
|
10 |
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris |
Terminated |
NCT03361345 |
Phase 2, Phase 3 |
Tranexamic Acid;Vehicle |
11 |
A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate (HPL) for Treatment of Periorbital Hyperpigmentation (Dark Circles) |
Unknown status |
NCT01644448 |
Phase 1, Phase 2 |
|
12 |
Long Term Effects on Skin Hyper Pigmentation With and Without Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for "Contour Deformities With Pigmentary Changes on Face" |
Unknown status |
NCT03564808 |
Phase 2 |
MSC |
13 |
A Randomized, Observer-Blinded, Vehicle-Controlled Study on the Safety and Efficacy of Twice Daily Application of Ruboxistaurin (DBI-102) Gel Vs.Vehicle Gel Vs. Hydroquinone Cream on Sun-Exposed and Sun-Protected Skin of Adults |
Recruiting |
NCT05511948 |
Phase 2 |
DBI-102;Vehicle gel;Hydroquinone Cream |
14 |
Evaluation of the Depigmenting Effect of Liftactiv B3 Serum (Split Face) in Patients With Mild to Moderate Facial Post-acne PIHP for 3 Months |
Recruiting |
NCT05327361 |
Phase 2 |
Liftactiv B3 |
15 |
Investigator Initiated Investigational New Drug Application to Study the Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease |
Terminated |
NCT02947022 |
Phase 1, Phase 2 |
Calcium DTPA;Zinc DTPA |
16 |
Tranexamic Acid Versus Fractional CO2 Laser in Post-inflammatory Hyperpigmentation in Acne Patients |
Unknown status |
NCT03765021 |
|
Tranexamic Acid |
17 |
Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients? |
Unknown status |
NCT00172302 |
|
vitamin C, intravenous injection |
18 |
Nanofat on Wound Healing and Scar Formation: a Randomized, Split-scar, Double Blind Trial |
Unknown status |
NCT03850119 |
|
|
19 |
Clinical, Histological and Biochemical Characterization of Hyperpigmented Lesion. |
Unknown status |
NCT01136629 |
|
|
20 |
Gingival Depigmentation With Er,Cr:YSGG and Diode Laser: Randomized Clinical Trial to Evaluate the Repigmentation and Patient Perceptions |
Completed |
NCT04680806 |
|
|
21 |
A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy |
Completed |
NCT04704245 |
|
epidermal growth factor (EGF)-containing ointment;Vehicle ointment |
22 |
A Combination of a Dermocosmetic and a Tainted Sunscreen Reduce Acne Severity and Signs of Post-inflammatory Hyperpigmentation in Subjects With a Fitzpatrick Phototype Ranging From IV to VI |
Completed |
NCT05601960 |
|
|
23 |
Efficacy and Safety of Combined Microneedling With Topical Glutathione Versus Carboxy Therapy in Treatment of Patients With Periorbital Hyperpigmentation |
Completed |
NCT04389788 |
|
|
24 |
Minimally Invasive Non-surgical Vitamin C Injection Versus the Conventional Surgical Depigmentation in Treatment of Gingival Hyperpigmentation of the Anterior Esthetic Zone: Prospective Study |
Completed |
NCT03719274 |
|
|
25 |
A Randomized, Evaluator-Blinded Clinical Study to Evaluate the Efficacy and Tolerability of an Investigational Light Therapy Mask on Subjects With Mild to Moderate Mottled Hyperpigmentation and Moderate to Severe Facial Wrinkles |
Completed |
NCT03312543 |
|
|
26 |
Topical Tranexamic Acid Versus Topical Vitamin C With Microneedling in Periorbital Hyperpigmentation; Comparative Study |
Completed |
NCT04697992 |
|
vitamin c 20%;Tranexamic acid 5mg/ml |
27 |
Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation, A Randomized Double-blind and Vehicle-Controlled Study |
Completed |
NCT03926845 |
|
|
28 |
Effect of Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation Following Q-switched Nd:YAG 532 nm Laser for Treatment of Facial Lentigines - A Pilot Study |
Completed |
NCT02492373 |
|
topical 0.05% Clobetasol propionate ointment |
29 |
Effect of Cold Air Cooling on the Incidence of Post Inflammatory Hyperpigmentation Following a Q-Switched Nd:YAG Laser Treatment of Acquired Bilateral Nevus of Ota-Like Macules |
Completed |
NCT00287001 |
|
|
30 |
Efficacy of Platelet-Rich Plasma (PRP) in the Treatment of Periorbital Hyperpigmentation |
Completed |
NCT03114514 |
|
|
31 |
PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation |
Completed |
NCT03933774 |
|
Tretinoin 0.05% cream;Placebo cream |
32 |
An In Vivo Model for Postinflammatory Hyperpigmentation: Part II |
Completed |
NCT02905903 |
|
Tricholoacetic Acid (TCA) |
33 |
A Multi-Center Clinical Trial to Evaluate the Efficacy and Tolerability for Treatment of Facial Hyperpigmentation and Photodamaged Skin With a Dual Regimen Treatment Containing Vitamin C and a Tinted SPF 45 Moisturizer |
Completed |
NCT05423873 |
|
|
34 |
Efficacy and Safety of Biocellulose Sheet From Coconut Juice Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment |
Completed |
NCT01806831 |
|
|
35 |
Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging |
Completed |
NCT04586816 |
|
|
36 |
Eye Dark Circles: Physiopathologic Aspects and Influence on Quality of Life in Subjects of Various Ethnicities and Fitzpatrick Skin Types Utilizing Non-invasive In Vivo Instrumentation and Validated Questionnaires |
Completed |
NCT03400202 |
|
|
37 |
Identification of Gene Biomarkers in Aging Skin; a Blinded, Prospective, Single-center, Clinical Study |
Completed |
NCT00884936 |
|
|
38 |
Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy |
Completed |
NCT03457246 |
|
|
39 |
Clinical Trial Study for the Use of Straberi Epistamp Needling Device to Treat Postinflammatory Hyperpigmentation (PIH) |
Recruiting |
NCT04740255 |
|
|
40 |
Comparison of the Effectiveness of Brightening Creams vs Laser Therapy (QS Nd:YAG 1064nm Laser) in Skin Hyperpigmentation After Sclerotherapy by Objective Measurement: A Randomized Controlled Monocentric Trial |
Recruiting |
NCT05165524 |
|
Triple cream |
41 |
Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation: A Randomized Control, Double Blinded-trial |
Recruiting |
NCT05206318 |
|
Topical Cysteamine;Topical Vehicle Control |
42 |
Characterization of Dyschromic Hypertrophic Scar: An Observational Clinical Trial |
Recruiting |
NCT04619589 |
|
|
43 |
Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in the Treatment of Melasma: A Split Face Study. |
Recruiting |
NCT04765930 |
|
|
44 |
The DBCG RT Natural Trial: Partial Breast Versus no Irradiation for Women >=60 Years Operated With Breast Conservation for an Early Breast Cancer: a Clinically Controlled Randomized Phase III Trial |
Recruiting |
NCT03646955 |
|
|
45 |
Comparison Of Aesthetic Techniques For Rejuvenation Of Genital Region: A Randomized Clinical Trial |
Recruiting |
NCT04998578 |
|
|
46 |
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color |
Not yet recruiting |
NCT05362929 |
|
|
47 |
Evaluation of the Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) |
Not yet recruiting |
NCT05625815 |
|
|
48 |
Quantifying Hyperpigmentation Response to Fractionated 1927nm in Fitzpatrick Skin Phototype V and VI: A Pilot Study |
Not yet recruiting |
NCT05493280 |
|
|
49 |
Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH). |
Not yet recruiting |
NCT05495503 |
|
|
50 |
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy |
Terminated |
NCT00771355 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
|